CONDENSED STATEMENTS OF CASH FLOWS - USD ($)		3 Months Ended			6 Months Ended	9 Months Ended
	Mar. 31, 2024	Sep. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2025	Dec. 31, 2024
Cash Flows from Operating Activities:
Net income	$ (15,397)	$ 144,634	$ 678,555	$ 981,482	$ 1,068,960	$ 1,578,036
Adjustments to reconcile net income to net cash used in operating activities:
Payment of operating costs through promissory note					44,577	0
Interest earned on investments held in Trust Account		(972,598)		(1,163,406)	(1,365,738)	(2,883,432)
Unrealized loss on investments held in Trust Account		(28,196)		(14,204)	(21,301)	82
Changes in operating assets and liabilities:
Prepaid expenses and other current assets					(160,331)	29,793
Accrued expenses					159,979	723,746
Net cash used in operating activities					(273,854)	(551,775)
Cash Flows from Investing Activities:
Investment of cash in Trust Account					(86,250,000)	0
Cash withdrawn from Trust Account for working capital purposes		0			0	600,000
Net cash provided by (used in) investing activities					(86,250,000)	600,000
Cash Flows from Financing Activities:
Proceeds from sale of shares, net of underwriting discounts paid					84,525,000	0
Proceeds from sale of Private Placement Shares					2,862,500	0
Underwriter reimbursement					862,500	0
Repayment of promissory note – related party					(157,056)	0
Payment of offering costs					(359,637)	0
Net cash provided by financing activities					87,733,307	0
Net Change in Cash					1,209,453	48,225
Cash – Beginning of period	$ 0		$ 1,129,684		0	1,129,684	$ 0
Cash – End of period		1,177,909		1,209,453	1,209,453	1,177,909	$ 1,129,684
Noncash investing and financing activities:
Deferred offering costs paid directly by Sponsor in exchange for the issuance of Class B ordinary shares					25,000	0
Deferred offering costs paid through promissory note - related party					112,479	0
Deferred underwriting fee payable		$ 0		$ 3,450,000	$ 3,450,000	$ 0